TY - GEN
T1 - Precocious atherosclerosis in rheumatoid arthritis
T2 - Role of traditional and disease-related cardiovascular risk factors
AU - Gerli, Roberto
AU - Sherer, Yaniv
AU - Bocci, Elena Bartoloni
AU - Vaudo, Gaetano
AU - Moscatelli, Sheila
AU - Shoenfeld, Yehuda
PY - 2007/6
Y1 - 2007/6
N2 - The risk of cardiovascular (CV) disease increases in patients with rheumatoid arthritis (RA). This is due to a number of different triggers including traditional and disease-related factors. Among established risk factors for CV disease, smoking may exert a more dangerous effect on arterial wall in RA than in the general population by a synergic effect with inflammatory processes of the disease. Although persistent inflammation and immune dysregulation of RA may contribute to favor other well-known CV risk factors, such as dyslipidemia, it is now clear that the disease itself represents an independent risk factor for CV disease by the action of RA chronic inflammatory process as well as humoral and cell-mediated immune mechanisms. There is evidence that CV risk is associated with severity and extension of the disease and it is of interest the fact that the presence of circulating anticyclic citrullinated peptide antibodies appears to be associated with stronger evidence of subclinical atherosclerosis in RA.
AB - The risk of cardiovascular (CV) disease increases in patients with rheumatoid arthritis (RA). This is due to a number of different triggers including traditional and disease-related factors. Among established risk factors for CV disease, smoking may exert a more dangerous effect on arterial wall in RA than in the general population by a synergic effect with inflammatory processes of the disease. Although persistent inflammation and immune dysregulation of RA may contribute to favor other well-known CV risk factors, such as dyslipidemia, it is now clear that the disease itself represents an independent risk factor for CV disease by the action of RA chronic inflammatory process as well as humoral and cell-mediated immune mechanisms. There is evidence that CV risk is associated with severity and extension of the disease and it is of interest the fact that the presence of circulating anticyclic citrullinated peptide antibodies appears to be associated with stronger evidence of subclinical atherosclerosis in RA.
KW - Anti-CCP antibodies
KW - Atherosclerosis
KW - Dyslipidemia
KW - Intima-media thickness
KW - Rheumatoid arthritis
KW - Smoking
UR - http://www.scopus.com/inward/record.url?scp=34447651227&partnerID=8YFLogxK
U2 - 10.1196/annals.1422.038
DO - 10.1196/annals.1422.038
M3 - ???researchoutput.researchoutputtypes.contributiontobookanthology.conference???
C2 - 17894000
AN - SCOPUS:34447651227
SN - 157331708X
SN - 9781573317085
T3 - Annals of the New York Academy of Sciences
SP - 372
EP - 381
BT - Autoimmunity, Part D
PB - Blackwell Publishing Inc.
ER -